AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33380535 — intervention group
Group type: COMPARATOR
Intervention: Engerix® (t = 0, 4, 24 weeks)
Number of subjects: 48
Study 34050419 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stitch technique (USP 2-0 single thread)
Number of subjects: 425
Study 34050419 — intervention group
Group type: COMPARATOR
Intervention: Long-stitch technique (USP 1 double loop)
Number of subjects: 425
Study 34050419 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stitch technique
Number of subjects: 425
Study 33734057 — intervention group
Group type: EXPERIMENTAL
Intervention: RPH-104 treatment
Number of subjects: 34
Study 33734057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 35254199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganilever pre-filled syringe (PFS)
Number of subjects: 236
Study 35254199 — intervention group
Group type: COMPARATOR
Intervention: Orgalutran
Number of subjects: 236
Study 35241174 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 78
Study 35241174 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 78
Study 35247512 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-poor platelet-rich plasma (Lp-PRP) injections (3 injections at the tendon repair site during surgery, at days 7 and 14 after surgery)
Number of subjects: 89
Study 35247512 — intervention group
Group type: COMPARATOR
Intervention: Control group (double-row suture-bridge arthroscopic rotator cuff repair alone)
Number of subjects: 89
Study 35247512 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-poor platelet-rich plasma (Lp-PRP) injections
Number of subjects: 89
Study 35247512 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study 32888985 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate hydrogel containing 0.5% hydrogen sulfide (H2S)
Number of subjects: 0
Study 32888985 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate hydrogel containing higher concentrations of H2S
Number of subjects: 0
Study 32888985 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate hydrogel (unspecified concentration)
Number of subjects: 0
Study 36198291 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-h time-restricted eating (TRE)
Number of subjects: 137
Study 36198291 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 137
Study 33705623 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC plus Simvastatin (40 mg/d orally)
Number of subjects: 0
Study 33705623 — intervention group
Group type: COMPARATOR
Intervention: FAC plus placebo (40 mg/d)
Number of subjects: 0
Study 33705623 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC plus Simvastatin
Number of subjects: 0
Study 33183671 — intervention group
Group type: EXPERIMENTAL
Intervention: Power exercise training (PT)
Number of subjects: 24
Study 33183671 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control (Con)
Number of subjects: 24
Study 34914150 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual exposure to violent video games
Number of subjects: 402
Study 34914150 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisocial media content
Number of subjects: 402
Study 34914150 — intervention group
Group type: COMPARATOR
Intervention: Short-term violent gameplay
Number of subjects: 402
Study 34165258 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 440
Study 34165258 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 440
Study 34165258 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 440
Study 34165258 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with alcohol dependence
Number of subjects: 440
Study 33934038 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face simulation education program (F2F)
Number of subjects: 126
Study 33934038 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based simulation education program (WB)
Number of subjects: 126
Study 33740345 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF)
Number of subjects: 200
Study 33740345 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular platelet-rich plasma (PRP)
Number of subjects: 200
Study 35274286 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress ball
Number of subjects: 123
Study 35274286 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual eyeglasses
Number of subjects: 123
Study 35274286 — intervention group
Group type: COMPARATOR
Intervention: Control group (basic behaviour guidance without distraction)
Number of subjects: 123
Study 33766051 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity and Sleep Health (PAS)
Number of subjects: 440
Study 33766051 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control (CON)
Number of subjects: 440
Study 32272923 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 60
Study 32272923 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 60
Study 36082522 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 300
Study 32201897 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-8678
Number of subjects: 44
Study 32201897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 35170192 — intervention group
Group type: EXPERIMENTAL
Intervention: bremelanotide (3 times daily for 15 days)
Number of subjects: 57
Study 35170192 — intervention group
Group type: EXPERIMENTAL
Intervention: bremelanotide (twice-daily)
Number of subjects: 57
Study 35170192 — intervention group
Group type: EXPERIMENTAL
Intervention: bremelanotide (3 times daily)
Number of subjects: 57
Study 35170192 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 57
Study 33773535 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (12 weeks)
Number of subjects: 48
Study 33773535 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise program)
Number of subjects: 48
Study 33223974 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring/cutting balloons (SCB)
Number of subjects: 115
Study 33223974 — intervention group
Group type: COMPARATOR
Intervention: Rotational atherectomy (RA)
Number of subjects: 115
Study 33223974 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SCB and RA
Number of subjects: 115
Study 35893857 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP)
Number of subjects: 0
Study 35893857 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient tablets (Tablets)
Number of subjects: 0
Study 35893857 — intervention group
Group type: COMPARATOR
Intervention: Fortified beverage (Beverage)
Number of subjects: 0
Study 33762662 — intervention group
Group type: EXPERIMENTAL
Intervention: Seldinger technique by inexperienced practitioners (IE-S)
Number of subjects: 308
Study 33762662 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Seldinger technique by inexperienced practitioners (IE-MS)
Number of subjects: 308
Study 33762662 — intervention group
Group type: EXPERIMENTAL
Intervention: Seldinger technique by experienced practitioners (E-S)
Number of subjects: 308
Study 33762662 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Seldinger technique by experienced practitioners (E-MS)
Number of subjects: 308
Study 33762662 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both techniques in inexperienced practitioners
Number of subjects: 308
Study 33762662 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both techniques in experienced practitioners
Number of subjects: 308
Study 32825535 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Counseling (PAC) for 12 weeks
Number of subjects: 22
Study 32825535 — intervention group
Group type: COMPARATOR
Intervention: Control group (instructions about FITT in one meeting)
Number of subjects: 22
Study 36451623 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative therapy (OMTh) plus repositioning therapy
Number of subjects: 96
Study 36451623 — intervention group
Group type: COMPARATOR
Intervention: Light touch therapy (LTT) plus repositioning therapy
Number of subjects: 96
Study 33509413 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) implemented by trained staff of opioid treatment programs (OTPs)
Number of subjects: 0
Study 33509413 — intervention group
Group type: EXPERIMENTAL
Intervention: New methods of medication delivery implemented by OTPs
Number of subjects: 0
Study 33838579 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm Guided Treatment started with escitalopram (AGT-E)
Number of subjects: 980
Study 33838579 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm Guided Treatment started with mirtazapine (AGT-M)
Number of subjects: 980
Study 33838579 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 980
Study 34343545 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillofacial and oral massage (MOM)
Number of subjects: 158
Study 34343545 — intervention group
Group type: COMPARATOR
Intervention: Routine oral care and medication
Number of subjects: 158
Study 32334516 — intervention group
Group type: EXPERIMENTAL
Intervention: Work Stress Questionnaire (WSQ) combined with general practitioner (GP) training and GP feedback at consultation.
Number of subjects: 271
Study 32334516 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 271
Study 35924970 — intervention group
Group type: EXPERIMENTAL
Intervention: HK-PS23
Number of subjects: 70
Study 35924970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 32079426 — intervention group
Group type: EXPERIMENTAL
Intervention: circRNA expression profile in SCLC tissues
Number of subjects: 6
Study 32079426 — intervention group
Group type: EXPERIMENTAL
Intervention: circ-STXBP5L
Number of subjects: 6
Study 32079426 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioinformatics analysis of circ-STXBP5L
Number of subjects: 6
Study 33280419 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-economic variables (age, education, marital status, lactation period)
Number of subjects: 423
Study 33280419 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-economic variables (age, education, being housewife)
Number of subjects: 423
Study 33280419 — intervention group
Group type: EXPERIMENTAL
Intervention: Family size
Number of subjects: 423
Study 33280419 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-economic variables (marital status, age, lactation period)
Number of subjects: 423
Study 32710606 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance group (received stop cue and could press stop button)
Number of subjects: 66
Study 32710606 — intervention group
Group type: COMPARATOR
Intervention: Control group (received same instructions but could not avoid full heat intensity)
Number of subjects: 66
Study 32710606 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (after the test phase where avoidance was unavailable)
Number of subjects: 66
Study 36052694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate dehydrogenase (LDH) levels as a prognostic marker for mortality in COVID-19 patients
Number of subjects: 843
Study 32162741 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical red clover oil (20 drops twice a day for 4 weeks)
Number of subjects: 80
Study 32162741 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (control group, 20 drops twice a day for 4 weeks)
Number of subjects: 80
Study 35984574 — intervention group
Group type: EXPERIMENTAL
Intervention: Low MAP target (65 to 70 mmHg)
Number of subjects: 747
Study 35984574 — intervention group
Group type: COMPARATOR
Intervention: High MAP target (80 to 85 mmHg)
Number of subjects: 747
Study 35984574 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of mottling ≥ 6 hours during the first 24 hours
Number of subjects: 747
Study 35984574 — intervention group
Group type: EXPERIMENTAL
Intervention: Mottling < 6 hours and lactate ≥ 2 mmol/L
Number of subjects: 747
Study 34774225 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 1 mg/kg plus ipilimumab 3 mg/kg intravenously every 3 weeks for four doses, followed by nivolumab 3 mg/kg every 2 weeks for up to 2 years.
Number of subjects: 119
Study 33141524 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Active Rehabilitation (initiated 2 weeks after injury)
Number of subjects: 20
Study 33141524 — intervention group
Group type: COMPARATOR
Intervention: Standard Active Rehabilitation (initiated 4 weeks after injury)
Number of subjects: 20
Study 34464551 — intervention group
Group type: EXPERIMENTAL
Intervention: IRHD-WG
Number of subjects: 10
Study 34464551 — intervention group
Group type: COMPARATOR
Intervention: IRHD-XCP
Number of subjects: 10
Study 34414984 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam combined with palonosetron (group MP)
Number of subjects: 88
Study 34414984 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron alone (group P)
Number of subjects: 88
Study 34414984 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MP and P)
Number of subjects: 88
Study 32301492 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 2084
Study 32301492 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide (1.5 mg)
Number of subjects: 2084
Study 34797778 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-g gluten challenge
Number of subjects: 60
Study 34797778 — intervention group
Group type: COMPARATOR
Intervention: Sham (rice flour)
Number of subjects: 60
Study 33744225 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU/weekly for eight weeks)
Number of subjects: 0
Study 33744225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35904229 — intervention group
Group type: EXPERIMENTAL
Intervention: VCMX
Number of subjects: 20
Study 35904229 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTG
Number of subjects: 20
Study 33783365 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat group chat-based BG management
Number of subjects: 309
Study 33783365 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical prenatal care
Number of subjects: 309
Study 36137921 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 446
Study 36137921 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary time (ST)
Number of subjects: 446
Study 36137921 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated measures of MVPA and ST
Number of subjects: 446
Study 36137921 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF)
Number of subjects: 446
Study 34186503 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based behavioral intervention
Number of subjects: 51
Study 34186503 — intervention group
Group type: COMPARATOR
Intervention: Control group (written information about endocrine disruptors)
Number of subjects: 51
Study 32815077 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention focused on maternal diet and physical activity
Number of subjects: 114
Study 34349116 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1008
Study 34349116 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 1008
Study 34349116 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine-extended release
Number of subjects: 1008
Study 34349116 — intervention group
Group type: COMPARATOR
Intervention: Treatment type and anxiety symptoms
Number of subjects: 1008
Study 34349116 — intervention group
Group type: COMPARATOR
Intervention: FIBSER scale assessment
Number of subjects: 1008
Study 34349116 — intervention group
Group type: COMPARATOR
Intervention: Assessment at 8 weeks
Number of subjects: 1008
Study 35322469 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary family programme
Number of subjects: 62
Study 32465171 — intervention group
Group type: EXPERIMENTAL
Intervention: ReDS-guided strategy
Number of subjects: 250
Study 32465171 — intervention group
Group type: COMPARATOR
Intervention: Standard of care strategy
Number of subjects: 250
Study 34645287 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment plus usual care
Number of subjects: 0
Study 34523948 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD) for 12 weeks, ad libitum energy intake
Number of subjects: 0
Study 34523948 — intervention group
Group type: COMPARATOR
Intervention: Normal Diet (ND)
Number of subjects: 0
Study 35488195 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study 35488195 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study 34472698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg
Number of subjects: 0
Study 34472698 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg
Number of subjects: 0
Study 34472698 — intervention group
Group type: COMPARATOR
Intervention: Comparators (placebo, sitagliptin 100 mg, liraglutide 1.8 mg)
Number of subjects: 0
Study 36087843 — intervention group
Group type: EXPERIMENTAL
Intervention: TeaM OUT intervention
Number of subjects: 0
Study 36087843 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care
Number of subjects: 0
Study 33908629 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic index meal (HGI; GI: 100)
Number of subjects: 18
Study 33908629 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic index meal (LGI; GI: 19)
Number of subjects: 18
Study 34157132 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab (RZB) 150 mg
Number of subjects: 955
Study 35717531 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training group
Number of subjects: 18
Study 35717531 — intervention group
Group type: COMPARATOR
Intervention: No-video group
Number of subjects: 18
Study 32794582 — intervention group
Group type: EXPERIMENTAL
Intervention: D/L‐3‐hydroxybutyrate (hyperketotic condition)
Number of subjects: 6
Study 32794582 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo control)
Number of subjects: 6
Study 32825814 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet system using an elastic cuff and LOP (Group E)
Number of subjects: 98
Study 32825814 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet system using a conventional cuff and LOP (Group C)
Number of subjects: 98
Study 36232162 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression equations for aerobic exercise intensities at 50%, 60%, 70%, and 80%.
Number of subjects: 228
Study 36232162 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression equations for aerobic exercise intensities.
Number of subjects: 228
Study 32623005 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 loss-framed incentive to complete risk assessment and $25 unconditional incentive for colonoscopy completion
Number of subjects: 1977
Study 32623005 — intervention group
Group type: COMPARATOR
Intervention: Control group with risk assessment and direct access colonoscopy scheduling
Number of subjects: 1977
Study 32859118 — intervention group
Group type: EXPERIMENTAL
Intervention: DAGIS intervention (multicomponent, preschool-based, family-involving)
Number of subjects: 802
Study 32859118 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 802
Study 34236123 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric (resistance) biofeedback training
Number of subjects: 33
Study 34236123 — intervention group
Group type: COMPARATOR
Intervention: Isometric (non-resistance) biofeedback training
Number of subjects: 33
Study 34236123 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study 32599497 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose Protocol (LDP)
Number of subjects: 103
Study 32599497 — intervention group
Group type: COMPARATOR
Intervention: Conventional Dose Protocol (CDP)
Number of subjects: 103
Study 35720033 — intervention group
Group type: EXPERIMENTAL
Intervention: Gubitong Recipe (GBT)
Number of subjects: 0
Study 33709856 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Glycopyrronium Bromide 6.25 µg BID
Number of subjects: 733
Study 33709856 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Glycopyrronium Bromide 12.5 µg BID
Number of subjects: 733
Study 33709856 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Glycopyrronium Bromide 25 µg BID
Number of subjects: 733
Study 33709856 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Glycopyrronium Bromide 50 µg BID
Number of subjects: 733
Study 33709856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 733
Study 33709856 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label tiotropium 18 µg once daily
Number of subjects: 733
Study 32897319 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (abbreviated to four weekly 90‐minute sessions)
Number of subjects: 23
Study 33300990 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose (75 g in 300 mL drink)
Number of subjects: 69
Study 33300990 — intervention group
Group type: COMPARATOR
Intervention: Glucose (75 g in 300 mL drink)
Number of subjects: 69
Study 33300990 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose vs Glucose
Number of subjects: 69
Study 32493462 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS sessions over the left dorsolateral prefrontal cortex and right motor cortex
Number of subjects: 0
Study 32493462 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS session
Number of subjects: 0
Study 32493462 — intervention group
Group type: EXPERIMENTAL
Intervention: Two sequences of two daily tDCS sessions over 5 days (one active and one sham)
Number of subjects: 0
Study 32493462 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 0
Study 34667819 — intervention group
Group type: EXPERIMENTAL
Intervention: Webinar training
Number of subjects: 107
Study 34667819 — intervention group
Group type: EXPERIMENTAL
Intervention: Group discussion training
Number of subjects: 107
Study 34667819 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study 34293489 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 IgG only
Number of subjects: 3142
Study 34293489 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 IgM only
Number of subjects: 3142